Feb 23, 2022
Averix Bio Announces Submission of Drug Master File for its CBD Isolate in the U.S.
WILSON, N.C.--(BUSINESS WIRE)--Averix Bio today announces its submission of a Drug Master File (DMF) to the US Food & Drug Administration (FDA) for cannabidiol (CBD)...